These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 12176581)
1. Patients with high cholesterol levels benefit most from early withdrawal of corticosteroids. Rigotti P; Transplant Proc; 2002 Aug; 34(5):1797-8. PubMed ID: 12176581 [No Abstract] [Full Text] [Related]
2. Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study. Squifflet JP; Vanrenterghem Y; van Hooff JP; Salmela K; Rigotti P; Transplant Proc; 2002 Aug; 34(5):1584-6. PubMed ID: 12176495 [No Abstract] [Full Text] [Related]
3. Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil. Sola E; Alférez MJ; Cabello M; Burgos D; González Molina M Transplant Proc; 2002 Aug; 34(5):1689-90. PubMed ID: 12176537 [No Abstract] [Full Text] [Related]
4. Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation. Boots JM; van den Ham EC; Christiaans MH; van Hooff JP Transplant Proc; 2002 Aug; 34(5):1696-7. PubMed ID: 12176541 [No Abstract] [Full Text] [Related]
5. Prospective randomized pilot study of steroid withdrawal with mycophenolate mofetil in long-term cyclosporine-treated patients: 4-year follow-up. Budde K; Geissler S; Hallebach G; Waiser J; Fritsche L; Böhler T; Neumayer HH Transplant Proc; 2002 Aug; 34(5):1703-5. PubMed ID: 12176544 [No Abstract] [Full Text] [Related]
14. Successful steroid withdrawal at the end of the 1st year after renal transplantion in mycophenolate mofetil-treated patients. Budde K; Hallebach G; Geissler S; Fritsche L; Diekmann F; Waiser J; Neumayer HH Transplant Proc; 2002 Aug; 34(5):1700-2. PubMed ID: 12176543 [No Abstract] [Full Text] [Related]
15. The Benelux experience with the combination of tacrolimus and mycophenolate mofetil. Squifflet JP; Van Hooff JP; Vanrenterghem Y Transplant Proc; 1999 Nov; 31(7A):72S-74S. PubMed ID: 10576050 [No Abstract] [Full Text] [Related]
16. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients. Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M Transplant Proc; 1999; 31(1-2):1131-2. PubMed ID: 10083505 [No Abstract] [Full Text] [Related]
17. Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice. Vathsala A; Lu YM Transplant Proc; 2001; 33(7-8):3137-9. PubMed ID: 11750348 [No Abstract] [Full Text] [Related]
18. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Höcker B; John U; Plank C; Wühl E; Weber LT; Misselwitz J; Rascher W; Mehls O; Tönshoff B Transplantation; 2004 Jul; 78(2):228-34. PubMed ID: 15280683 [TBL] [Abstract][Full Text] [Related]
19. Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids. Akman B; Uyar M; Afsar B; Sezer S; Ozdemir FN; Haberal M Transplant Proc; 2007; 39(1):135-7. PubMed ID: 17275490 [TBL] [Abstract][Full Text] [Related]
20. Transplantation without maintenance corticosteroids in 1-haplotype and 2-haplotype HLA matched living-related renal transplant recipients treated with mycophenolate mofetil and cyclosporine. Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M Transplant Proc; 1999; 31(1-2):744-5. PubMed ID: 10083317 [No Abstract] [Full Text] [Related] [Next] [New Search]